<DOC>
	<DOCNO>NCT00559247</DOCNO>
	<brief_summary>The primary purpose study evaluate safety profile tolerability single oral dos BMS-650032 subject chronic hepatitis C infection</brief_summary>
	<brief_title>A Single Ascending Dose Study BMS-650032 HCV Infected Subjects</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<criteria>Chronically infect HCV genotype 1 Treatment naive treatment nonresponders treatment intolerant HCV RNA viral load ≥10*5 IU/mL BMI 18 35kg/m² Any significant acute chronic medical illness stable control medication consistent HCV infection Major surgery within 4 week study drug administration gastrointestinal surgery could impact absorption study drug Coinfection HIV HBV Women childbearing potential</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2010</verification_date>
</DOC>